Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Berube

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
British Journal of Haematology|April 5, 2016
A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myelomaTamara J Dunn, Shira Dinner, Elizabeth Price, et al.
International Journal of Hematology|May 27, 2018
A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myelomaShira Dinner, Tamara J Dunn, Elizabeth Price, et al.
Obstetrics and Gynecology|February 5, 2026
Pregnancy Outcomes Associated With Anemia in the First Trimester and Anemia Resolution by Late PregnancyAnna Booman, Brian T Bateman, Sara Siadat, et al.
Paediatric and Perinatal Epidemiology|October 30, 2025
Validation of International Classification of Diseases Diagnosis Codes for Anaemia During PregnancyAnna Booman, Brian T Bateman, Sara Siadat, et al.
Haematologica|October 14, 2011
Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemiaMichaela Liedtke, Clare J Twist, Bruno C Medeiros, et al.
American Journal of Hematology|September 28, 2010
Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experienceHolbrook E Kohrt, Samit Patel, Michelle Ho, et al.
BMC Medical Informatics and Decision Making|August 21, 2019
Thrombophilia testing in the inpatient setting: impact of an educational interventionHenry Kwang, Eric Mou, Ilana Richman, et al.
Haematologica|December 18, 2012
Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemiaDaniel A Pollyea, James Zehnder, Steve Coutre, et al.
Leukemia & Lymphoma|September 17, 2015
Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndromeRupa Narayan, Jacqueline S Garcia, Mary-Elizabeth M Percival, et al.
Journal of the American Heart Association|November 7, 2022
Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision-Making PathwayPaul J Wang, Ying Lu, Kenneth W Mahaffey, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
British Journal of Haematology|April 5, 2016
A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myelomaTamara J Dunn, Shira Dinner, Elizabeth Price, et al.
International Journal of Hematology|May 27, 2018
A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myelomaShira Dinner, Tamara J Dunn, Elizabeth Price, et al.
Obstetrics and Gynecology|February 5, 2026
Pregnancy Outcomes Associated With Anemia in the First Trimester and Anemia Resolution by Late PregnancyAnna Booman, Brian T Bateman, Sara Siadat, et al.
Paediatric and Perinatal Epidemiology|October 30, 2025
Validation of International Classification of Diseases Diagnosis Codes for Anaemia During PregnancyAnna Booman, Brian T Bateman, Sara Siadat, et al.
Haematologica|October 14, 2011
Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemiaMichaela Liedtke, Clare J Twist, Bruno C Medeiros, et al.
American Journal of Hematology|September 28, 2010
Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experienceHolbrook E Kohrt, Samit Patel, Michelle Ho, et al.
BMC Medical Informatics and Decision Making|August 21, 2019
Thrombophilia testing in the inpatient setting: impact of an educational interventionHenry Kwang, Eric Mou, Ilana Richman, et al.
Haematologica|December 18, 2012
Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemiaDaniel A Pollyea, James Zehnder, Steve Coutre, et al.
Leukemia & Lymphoma|September 17, 2015
Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndromeRupa Narayan, Jacqueline S Garcia, Mary-Elizabeth M Percival, et al.
Journal of the American Heart Association|November 7, 2022
Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision-Making PathwayPaul J Wang, Ying Lu, Kenneth W Mahaffey, et al.
Pageof 2